Medplus Health: Profit Surge With Caution on Valuation..!

Medplus Health has shown solid profit momentum in Q1 FY26. While sales grew modestly by 4% YoY to ₹1,543 crore, EBIDT rose 39% to ₹131 crore, pointing to better cost control and improved operating efficiency. The real highlight is the 195% YoY jump in net profit to ₹42.3 crore and EPS rising equally to ₹3.54 — a clear signal of stronger profitability. However, the stock is currently trading at a high PE of 61.5, which suggests the market is pricing in aggressive future growth. For long-term investors, the improving fundamentals are encouraging — but the premium valuation demands continued performance to justify the price tag.